LexBio

LexBio, founded by Dr. Li Xing, collaborates with international new drug research experts in the industry. The R&D team members have many years of experience in drug development. The company's core technology adopts AI algorithms and computer-aided drug design (CADD), making it an innovative technology enterprise with the vision of developing high-quality small molecule new drugs.